Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Jun 10, 2026 - 00:41:21
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value
Synopsis: Jim Tananbaum, Founder & CEO of Foresite Capital, joins Rahul Chaturvedi to dissect the patterns driving biotech innovation, the role of macroeconomic cycles in venture performance, and how disciplined science...
About This Episode
Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: Jim Tananbaum, Founder & CEO of Foresite Capital, joins Rahul Chaturvedi to dis...
Podcast
This episode belongs to Biotech 2050 Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Nov 5, 2025, 00:23:17 long, audio available.
Related Episodes
Continue listening to more episodes from Biotech 2050 Podcast.
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
May 13, 2026 - 00:33:34
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Apr 16, 2026 - 00:23:07
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Mar 6, 2026 - 00:14:16
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Feb 11, 2026 - 00:25:06
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Feb 10, 2026 - 00:26:40
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
Jan 28, 2026 - 00:21:53